Despite worldwide prevention programs, the incidence for cutaneous melanoma is continuously increasing. Mucosal melanoma (MM) represents a rare but highly aggressive phenotype of common melanoma with predilection in the sinonasal system. Far away from ultraviolet sun exposure, the molecular mechanisms underlying tumorigenesis and the highly aggressive clinical behavior are poorly understood. In many solid malignomas of the head and neck region, p53 tumor suppressor functions as oncogene due to p53 protein stabilizing mutation. Interestingly, the vast majority of MM demonstrates constitutively expressed p53 protein, with protein stabilizing mutations being rare. Abrogated activation of p53 target genes results in derogation of the apoptotic ...
Mucosal melanoma (MM) is a rare melanoma subtype that originates from melanocytes within sun-protect...
The transcription factor p53 is frequently lost during tumor development in solid tumors; however, m...
Despite modern achievements in therapy of malignant melanomas new treatment strategies are welcomed ...
Background: Metastatic melanoma represents a major clinical problem. Its incidence continues to rise...
p53 is the central member of a critical tumor suppressor pathway in virtually all tumor types, where...
The inactivation of the p53 tumor suppressor pathway, which often occurs through mutations in TP53 (...
Metastatic melanoma is one of the most aggressive tumors, with frequent mutations affecting componen...
Cutaneous melanoma is the most aggressive form of skin cancer. Despite the significant advances in t...
The inactivation of the p53 tumor suppressor pathway, which often occurs through mutations in TP53 (...
Inactivation of the p53 pathway that controls cell cycle progression, apoptosis and senescence, has ...
One of the defining features of aggressive melanomas is their complexity. Hundreds of mutations and ...
Mutations in the p53 tumor suppressor gene, located at chromosomal locus 17pI3, are the most commonl...
Purpose: Metastatic melanoma is largely unresponsive to DNA-damaging chemotherapy agents, although W...
AbstractThe tumour suppressor p53 is a master sensor of stress and it controls the expression of hun...
Skin cancers are the most common types of cancer worldwide, and their incidence is increasing. Melan...
Mucosal melanoma (MM) is a rare melanoma subtype that originates from melanocytes within sun-protect...
The transcription factor p53 is frequently lost during tumor development in solid tumors; however, m...
Despite modern achievements in therapy of malignant melanomas new treatment strategies are welcomed ...
Background: Metastatic melanoma represents a major clinical problem. Its incidence continues to rise...
p53 is the central member of a critical tumor suppressor pathway in virtually all tumor types, where...
The inactivation of the p53 tumor suppressor pathway, which often occurs through mutations in TP53 (...
Metastatic melanoma is one of the most aggressive tumors, with frequent mutations affecting componen...
Cutaneous melanoma is the most aggressive form of skin cancer. Despite the significant advances in t...
The inactivation of the p53 tumor suppressor pathway, which often occurs through mutations in TP53 (...
Inactivation of the p53 pathway that controls cell cycle progression, apoptosis and senescence, has ...
One of the defining features of aggressive melanomas is their complexity. Hundreds of mutations and ...
Mutations in the p53 tumor suppressor gene, located at chromosomal locus 17pI3, are the most commonl...
Purpose: Metastatic melanoma is largely unresponsive to DNA-damaging chemotherapy agents, although W...
AbstractThe tumour suppressor p53 is a master sensor of stress and it controls the expression of hun...
Skin cancers are the most common types of cancer worldwide, and their incidence is increasing. Melan...
Mucosal melanoma (MM) is a rare melanoma subtype that originates from melanocytes within sun-protect...
The transcription factor p53 is frequently lost during tumor development in solid tumors; however, m...
Despite modern achievements in therapy of malignant melanomas new treatment strategies are welcomed ...